Evidence map›Paper›PMID 22561151›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

The skin, a novel niche for recirculating B cells.

Skye A Geherin, Sarah R Fintushel, Michael H Lee, R Paul Wilson, Reema T Patel, Carsten Alt, Alan J Young, John B Hay, Gudrun F Debes

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Germinal center responses at barrier organ sites.Current opinion in immunology · 2026
    Review
  3. Review
  4. Review
  5. B cells in non-lymphoid tissues.Nature reviews. Immunology · 2025
    Review
  6. Article
  7. Article
  8. Breg-Mediated Immunoregulation in the Skin.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Resident Memory B Cells in Barrier Tissues.Frontiers in immunology · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Skye A GeherinDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.
Sarah R Fintushel
Michael H Lee
R Paul Wilson
Reema T Patel
Carsten Alt
Alan J Young
John B Hay
Gudrun F Debes
University of Pennsylvania · USSouth Dakota State University · USStanford University · USUniversity of Toronto · CA

Funding

TRAINING PROGRAM/RHEUMATIC DISEASEST32AR007442 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BEHRENS, EDWARD M, MERKEL, PETER A · 1986 to 2018
$5.8M
PARASITOLOGY: MODERN APPROACHEST32AI007532 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HERBERT, DE'BROSKI R · 1998 to 2022
$5.0M
Understanding molecular mechanisms underlying the formation of the blue nevus andP30AR057217 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI STANLEY, JOHN R · 2009 to 2013
$3.2M
Regulation of T cell egress from inflamed skinR01AR056730 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI DEBES, GUDRUN PHILOMENA · 2009 to 2013
$1.7M
NIAID NIH HHS T32 AI007532NIAID NIH HHS T32AI007532NIAMS NIH HHS 5T32AR7442-25NIAMS NIH HHS AR056730NIAMS NIH HHS P30 AR057217NIAMS NIH HHS P30-AR057217-03NIAMS NIH HHS R01 AR056730NIAMS NIH HHS T32 AR007442
6 · The paper itself

Abstract

B cells infiltrate the skin in many chronic inflammatory diseases caused by autoimmunity or infection. Despite potential contribution to disease, skin-associated B cells remain poorly characterized. Using an ovine model of granulomatous skin inflammation, we demonstrate that B cells increase in the skin and skin-draining afferent lymph during inflammation. Surprisingly, skin B cells are a heterogeneous population that is distinct from lymph node B cells, with more large lymphocytes as well as B-1-like B cells that coexpress high levels of IgM and CD11b. Skin B cells have increased MHC class II, CD1, and CD80/86 expression compared with lymph node B cells, suggesting that they are well-suited for T cell activation at the site of inflammation. Furthermore, we show that skin accumulation of B cells and Ab-secreting cells during inflammation increases local Ab titers, which could augment host defense and autoimmunity. Although skin B cells express typical skin-homing receptors, such as E-selectin ligand and α-4 and β-1 integrins, they are unresponsive to ligands for chemokine receptors associated with T cell homing into skin. Instead, skin B cells migrate toward the cutaneously expressed CCR6 ligand CCL20. Our data support a model in which B cells use CCR6-CCL20 to recirculate through the skin, fulfilling a novel role in skin immunity and inflammation.

Indexed as

AnimalsB-LymphocytesB-Lymphocyte SubsetsChemotaxis, LeukocyteDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryInflammationReceptors, ChemokineSheepSkinReceptors, Chemokine

Identifiers

PMID22561151
PMCPMC3370056
OpenAlexW2142214534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.